Table 2.
Patient and tumor characteristics after matching
| LSPDP (N = 173) | LDPS (N = 173) | P-value | SMD | |
|---|---|---|---|---|
| Age, years (SD) | 58 (15) | 56 (16) | 0.26 | 0.13 |
| Female, n (%) | 109 (63) | 112 (65) | 0.74 | 0.05 |
| Tumor size, mm (SD) | 32 (21) | 33 (22) | 0.55 | 0.05 |
| Histology, n (%) | ||||
| NET | 66 (38) | 57 (33) | ||
| MCN | 43 (25) | 51 (29) | ||
| SCN | 20 (11.5) | 8 (5) | ||
| IPMN | 20 (11.5) | 29 (17) | ||
| Chronic pancreatitis/pseudocyst | 8 (5) | 14 (8) | ||
| Other cyst | 7 (4) | 5 (3) | ||
| RCC metastasis | 3 (2) | 1 (0.5) | ||
| SPT | – | 5 (3) | ||
| No tumor | 1 (0.5) | – | ||
| Other metastasis | 2 (1) | 3 (1.5) | ||
| Other | 1 (0.5) | – | ||
| GIST | 1 (0.5) | – | ||
| Acinar cell carcinoma | 1 (0.5) | – |
LSPDP laparoscopic spleen-preserving distal pancreatectomy, LDPS laparoscopic distal pancreatectomy with splenectomy, SMD standardized mean difference, NET neuroendocrine tumor, MCN mucinous cystic neoplasm, SCN serous cystic neoplasm, IPMN intraductal papillary mucinous neoplasm, RCC renal cell carcinoma, SPT solid papillary tumor